Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

Clinical trial NCT07132567 · RECRUITING

Trial details

NCT number: NCT07132567
Sponsor: Kyowa Kirin Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Mycosis Fungoides Sezary Syndrome

Start date: 2025-05-02
Primary completion: 2028-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.